Cargando…
Daptomycin: a comparison of two intravenous formulations
Daptomycin is a cyclic lipopeptide antibacterial agent with potent bactericidal activity against a broad range of Gram-positive organisms. In 2003, daptomycin for injection received approval from the US Food and Drug Administration (FDA) for the treatment of patients with complicated skin and skin s...
Autores principales: | Frankenfeld, Celeste, Mittal, Sachin, Melendez, Yanira, Mendez-Vigo, Luke, Lamp, Kenneth C, Keller, Kaitlin N, Bertolami, Shellie R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030942/ https://www.ncbi.nlm.nih.gov/pubmed/29988771 http://dx.doi.org/10.2147/DDDT.S167010 |
Ejemplares similares
-
A retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin
por: Hermsen, Elizabeth D., et al.
Publicado: (2016) -
Daptomycin in bone and joint infections: a review of the literature
por: Rice, Dennis A. K., et al.
Publicado: (2008) -
Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs
por: Crompton, Jason A., et al.
Publicado: (2010) -
Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections
por: Aikawa, Naoki, et al.
Publicado: (2012) -
Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration
por: Kennedy, Gerard, et al.
Publicado: (2015)